S_umary The differentiation of A549. a human tumour cell line from type II pneumocytes. can be induced by a crude fibroblast-derived factor (FDF) isolated from the conditioned medium of glucocorticoid-treated lung fibroblasts. In the present report. we have used alkaline phosphatase as a differentiation marker to investigate the activity of a number of growth factors as potential candidates for this paracrine activity. This showed that insulin. interleukin 6 (IL-6), and interferon m (IFN-a) Edelson et al. (1988) showed that maturation of the type II pneumocyte is accompanied by an increase in alkaline phosphatase (AP) activity, and this marker has been used in the present study to demonstrate that conditioned medium from DX-treated fibroblasts (DXCM) also induces AP activity in A549 cells. DX is active on A549 cells alone, but its activity is greatly enhanced by conditioned medium from DX-treated lung fibroblasts. However, while this conditioned medium is active for the induction of PS synthesis after DX had been removed (Speirs et al., 1991) , the continued presence of DX is required for induction of AP activity. The precise role of DX is as yet unclear.
methylsulphoxide (DMSO) and hexamethylene bisacetimide (HMBA), are often not effective in vivo or are limited by toxicity (Egonrn et al., 1987; Ward et al., 1991) . Clinical success with retinoids (Meyskens, 1993) and the differentiation-inducing effect of glucocorticoids (McLean et al., 1986) and cytokines (Wuarin et al., 1991) in vitro suggest that physiological regulation may be feasible, at least for a component of the tumour cell population, and applicable in combination with cytotoxic chemotherapy (Huang and Waxman, 1994) .
Cell interaction is clearly established as a major component in the regulation of differentiation in embryonic development (Jessell and Melton, 1992) , and observations on skin (Fusenig, 1992) , prostate (Cunha et al., 1983) , uterus (Cunha and Young, 1992) and breast (Adams et al.. 1991) suggest that cell interaction continues to be important in adult development and homeostasis. Frequently, the status of one or both interacting cell populations is governed by systemic hormone activity (Cunha et al., 1983; Cunha and Young, 1992) . The maturation of lung alveoli at parturition illustrates very effectively, both the need for cell interaction and the indirect hormonal regulation of the differentiated function of lung epithelium. The onset of pulmonary surfactant (PS) synthesis at birth is regulated by glucocorticoid via its action on lung fibroblasts, causing them to secrete fibrocyte-pneumocyte factor (FPF), which stimulates PS synthesis in the type II pneumocyte (Smith and Fletcher. 1979) .
In a previous report (Speirs et al., 1991) , we showed that the A549 cell, a tumour of human type II pneumocytes (Lieber et al., 1976) Edelson et al. (1988) showed that maturation of the type II pneumocyte is accompanied by an increase in alkaline phosphatase (AP) activity, and this marker has been used in the present study to demonstrate that conditioned medium from DX-treated fibroblasts (DXCM) also induces AP activity in A549 cells. DX is active on A549 cells alone, but its activity is greatly enhanced by conditioned medium from DX-treated lung fibroblasts. However, while this conditioned medium is active for the induction of PS synthesis after DX had been removed (Speirs et al., 1991) The medium was then removed, the cells washed in phosphate-buffered saline (PBS), frozen and thawed three times in the residue after the last PBS wash, and alkaine phosphatase activity determined on the lysate.
Alkaline phosphatase assay Alkaline phosphatase was assayed by Sigma Kit 104. Briefly, p-nitrophenyl phosphate was added to the cell lysate in the microtitration plate along with assay buffer at pH 10.5, in a total volume of 100 PI. The plate was incubated for 1 h at 3TC and then 100 jl of 0.1 M sodium hydroxide was added and the absorbance of the free p-nitrophenol detamined on a BioRad enzyme-linked immunoasorbent assay (ELISA) plate reader at 405 nm. Cell numbers were determined in a replicate plate, and the activity of alkalin phosphatase expressed as pmol of p-nitrophenol released per hour per 101 cels.
Plasminen activator Plasminogen activator activity was masured by a chromogenic assay which cleaves p-nitroanilie from a conjugated peptide S-2251 (Kabi-Vitrum) in the presnce of 0.15 mg ml-l poly-D-lysine (Whur et al., 1980) . The yellow product was read on an ELISA plate reader at 405 nm.
Growth factors Growth factors were obtained as indicated in Table I .
Bioassay of IL-6 was assayed by the method of Wadhwa et al. (1991) . Briefly, B9 myeloma cells were exposed to a series of dilutions of standard IL-6, CM, DX, DXCM and CM + DX, in the presence and absence of anti-IL-6 antibody (NlBSC), and the cell number determined 3 days later while the cells were in exponential growth. The sensitivity of the assay was 5 pg ml-' and the inter-and intra-assay coefficients of variance were both <10%. There was no cross-reactivity with IL-2, IL-3, IL-4, IL-5, tumour necrosis factor (TNF), GM-CSF and IFN-'y. The induction with DX alone tended to vary from one experiment to another (1.5-fold to 5-fold; mean= 2.5-fold, s.e.m. = 0.06-fold), and when the induction was carried out in different DX concentrations it was found that 0.25 gLM fell close to the mid-point of inflection of the curve of activity vs DX concentration (Figure 1 ) where minor fluctuations in environmental conditions may have had the greatest effect on AP induction. When CM and DXCM were compared with DX alone, it was seen that DXCM was active at 50-100 nM DX, whereas little or no effect was observed with DX alone. CM + DX only showed acti'vity greater than DX alone at higher DX concentrations (>0.1I M).
A549 cells were treated with medium from post-confluent fibroblasts, conditioned in the presence (DXCM) or absence Tabe Some samples were exposed to medium conditioned without DX but with 0.25 JM DX added during exposure to the A549 cells (CM + DX). DX was stimulatory (Table II) absence of DX. peaking at 1.0 ng ml-'. and only about 500 in its presence (Figure 3d (Figure 6 ). Cells exposed to IFN-a. IL-6 and insulin, alone or combined, also showed reversal of alkaline phosphatase induction with a similar half-life. These experiments were conducted at a relatively high cell density and in 1% serum, added after the induction period. While cell proliferation did occur. it had increased by only 36% by 7 days after removal of DXCM. considerably less than the doubling that would be necessary to dilute out the effect of the induction. On removal of the combined growth factors and DX. cell number was higher at the time of removal and had only increased by <2% by 7 days (Table   III) .
IL-6 bioassay IL-6 has been shown to be a specific mitogen for B9 myeloma cells. so stimulation of myeloma proliferation (Wadhwa et al., 1991) was used to assay IL-6 in CM and DXCM. CM contained significant amounts of IL-6 (Table  IV) . but this was reduced 10-fold in DXCM.
Plasminogen activator Plasminogen activator activity was measured in microtitration plate cultures, following exposure to 1.0 jg ml-' insulin.
2.5;jg ml-' IL-6 and 500 ng ml-' IFN-a, individually. bined and with and without 0.25 gM DX. DX inhibited PA activity in all combinations, while all three growth factors increased PA activity, IL-6 giving the greatest increase (Table  V) . The combined effects of the growth factors were not additive, and all three factors together showed only slightly greater activity than the control. The reduction of PA by DX was antagonised by IL-6 and, to a lesser degree, by IFN-x and insulin; the combination of all three factors completely blocked the inhibition produced by DX.
Discusso
Alkaline phosphatase activity has been described as a marker from the PS-inducing activity of conditioned medium from DX-treated fibroblasts (DXCM), where induction was maintained after removing DX, and in a semipurified extract (FDF) obtained from DXCM. We are now undertaking purification studies to determine whether the activity in fibroblast-conditioned medium responsible for AP induction is the same as that which induced PS in previous studies. A number of growth factors have been shown to be active in the AP assay, namely IFN-a, IL-6 and insulin. IL-6 has been shown to be a paracrine factor in uterus (Jacobs et al., 1992) , and IFN-x has been associated with differentiation in a number of systems (Kohlhepp et al., 1987; Pfeffer and Eisenkraft, 1991) . In the present series of expenrments activity was dependent on DX when the growth factors were used individually. Although significant activity was demonstrable in growth factor combinations without DX, DX still more than doubled the response.
IL-6 was shown to be present in CM but reduced in DXCM, making it unlikely that IL-6 is the major activity in DXCM, although it may be responsible for much of the activity in CM + DX. IFN-z was also shown to be active, though not as active as IL-6, and dependent on DX. The other major active factor was insulin. While both IFN and IL-6 are reasonable candidates for paracrine factors released by fibroblasts, this is not a likely role for insulin. Insulin has been shown to be active in the induction of differentiation of breast secretory epithelium (Stockdale and Topper, 1966; Gaben-Gogneville et al., 1990; Takabashi et al., 1991) and it may have a general systemic role. IGF-I and IGF-II have been shown to act as paracrine factors (Quinn et al., 1990; Eicher et al., 1993) and to be released from fibroblasts. However, neither of these factors demonstrated any significant activity in the present system, although IGF-I gave 75% stimulation in the PS assay (Speirs et al., 1991) . Use of antibody to the IGF-I receptor did not block induction by insulin (data not shown). No attempt was made to assay for IGF-binding proteins; these could have been released from either the A549 cells or the fibroblasts and could have altered the response to exogenous IGF.
EGF and TGF-x were inhibitory in the absence of DX, with EGF being the more potent. DX was able to reverse the inhibitory effect of both of these factors. TGF-P was also inhibitory, as previously reported (Torday and Kourem concentrations of TGF-P. As well as facilitating the stimulation of positively acting factors, DX may be able to antagonise inhibition by negatively acting factors. In the case of IL-la, however, the degree of inhibition was greater in the presence of DX.
Basic FGF (FGF-2) gave 75% induction of AP in the absence of DX, and this was not increased by DX. Basic FGF also stimulates PS synthesis by 83% (Speirs et al., 1991) . This suggests that bFGF might have a role in conditioned medium, but, as it is not DX-dependent, it is not the major activity in the induction of AP. Its activity was also much less than FDF in the induction of PS synthesis (Speirs et al., 1991) , so, although it may be contributory, it is not likely to be the sole factor. Many growth factors of the FGF family have been shown to be dependent on heparin sulphate proteoglycan (HSPG) for activity (Klagsbrun and Baird, 1991) . It is possible that HSPG was present as a contaminant in FDF prepared by Speirs et al. (1991) , as the factor was not purified to homogeneity, and that this promoted the higher activity of FDF. The role of bFGF may therefore be more significant in PS synthesis than in AP induction. Preliminary experiments suggest that exogenous heparin has no effect on induction of AP by DXCM or CM + DX (C McCormick and RI Freshney, unpublished observations). Mackie et al. (1988) showed that glucocorticoids could promote a shift from free hyaluronic acid to cell-associated sulphated proteoglycans, particularly heparan sulphate, in human glioma cultures. Such an alteration in the present system could have a profound effect on growth factor activity, stability and receptor binding (Casillas et al., 1991; Klagsbrun and Baird, 1991; Rusnati et al., 1993) . Preliminary studies with DX treatment of A549 (J Robertson and RI Freshney, unpublished observations) suggest that the effect of DX on promoting DXCM activity is relatively stable and is still present 3 days after DX removal. This would be compatible with matrix alteration. rather than an effect on signal transduction. which might be expected to be more transitory.
It is also possible that DX may affect the receptor status of the A549 cells. Up-regulation of the receptors for each of the effective factors is likely to enhance their effect, but, again, a half-life of 7 days would not be expected for receptor turnover, which is more likely to be in the region of a few hours. The receptor status of the A549 cells has not been determined but is clearly worthy of investigation as it may explain some of the differences in responsiveness to different factors.
Withdrawal of DXCM after induction of AP showed that the AP activity of the A549 cells decayed over a period of more than 1 week, suggesting that the phenotypic change is reversible, but with a relatively slow reversion rate. While the cell number increased with continued culture after removal of inducers. the amount of cell replication was not sufficient to account for the loss of activity, unless differentiated cells were actively lost from the population, e.g. by apoptosis.
while undifferentiated cells proliferated. There was no obvious sign of this (increase in floating dead cells) but it will require more detailed analysis.
So far, the identity of the active factor(s) in fibroblastconditioned medium remains unknown, but 
